HIGHLIGHTS
- who: Jing Lin from the (The Cancer Genome Atlas) and GTEx (Gene Tissue Expression) databasesThe expression of , in different tumor stages and grades was confirmed using UALCAN (The University of Alabama at Birmingham Cancer data analysis Portal) database based on the TCGA_LIHC (Liver Hepatocellular Carcinoma) data. In addition, the protein expression level of , was further verified by immunohistochemical staining in tumor tissues from patients with HCC using the HPA (Human Protein Atlas) database. Kaplan-Meier survival analysis have published the article: SPATS2 is correlated with cell cycle progression and immune cells infiltration in hepatocellular carcinoma, in the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.